The global Patient-controlled Analgesia Pumps Market is anticipated to register a CAGR of 5% during the forecast period. The global market valuation is USD 447 million in 2023 and is expected to reach USD 729.1 million by 2033.
The increasing prevalence of chronic diseases such as cardiovascular disease is increasing the demand for patient-controlled analgesia pumps. The growing number of cancer cases and performed surgeries are fueling the global market size. Healthcare professionals are increasing the demand for patient-controlled analgesia pumps to manage patients' post-operative pain.
The growing aging population, expanding healthcare infrastructure, and increasing chronic pain are significantly driving the global market. Rapidly growing advanced technologies are developing safe, efficient, and user-friendly devices to improve patient outcomes. Enhanced drug delivery systems integrated with electronic health records help to monitor patients' health.
The adoption of portable patient-controlled analgesia pumps for home healthcare is driving the global market trend. Patients prefer these devices with cost-effective solutions to reduce hospital costs. Healthcare manufacturers are promoting patients' health by developing standardized devices with stringent regulatory guidelines.
Increasing awareness through education campaign and training programs are ensuring patients about the benefits of patient-controlled analgesia devices. The key companies are partnering with pharmaceutical companies to increase the adoption of smart technologies to promote their advanced products.
Key Highlights
| Attributes | Details |
|---|---|
| Patient-controlled Analgesia Pumps Market Size, 2023 | USD 447 million |
| Patient-controlled Analgesia Pumps Market Size, 2033 | USD 729.1 million |
| Value-based CAGR from 2023 to 2033 | 5% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The global Patient-controlled Analgesia Pumps Market grew at a significant rate between 2018 and 2022. The global market captured a valuation of USD 421.9 million with a CAGR of 5.1% in 2022. Healthcare professionals are increasing the adoption of patient-controlled analgesia devices to deliver the required drugs at the right place.
Around 50% of patients are hospitalized due to chronic pain, and 30% suffer persistent pain due to cancer disease. Patients who are facing moderate or little pain are increasing the adoption of portable patient-controlled analgesia devices at home. The rapidly growing advanced technologies in the healthcare sector are improving patient outcomes.
Key companies are integrating smart devices to relieve chronic patients and satisfy their needs. The adoption of sophisticated, wireless, and user-friendly equipment is expanding the patient-controlled analgesia pumps market size. These companies are likely to achieve their goals by acquiring maximum revenue during the forecast period.
| Countries | Share (2023 to 2033) |
|---|---|
| United States | 32.6% |
| Japan | 4.3% |
| Germany | 7.1% |
| Countries | CAGR (2023 to 2033) |
|---|---|
| Australia | 5.6% |
| China | 5.1% |
| India | 5.3% |
| United Kingdom | 4.5% |
The United States is estimated to capture a share of 32.6% of the global market by 2033. The growing numbers of generic patients, diabetes patients, and advanced healthcare settings are fueling the United States patient-controlled analgesia pumps market. The United States is likely to dominate the global market due to the higher rate of chronic disorders in the country.
In 2019, the most common deadly disease in the United States was kidney disease. Around 80 million people suffer from kidney disease in the country. Healthcare professionals are adopting patient-controlled analgesia devices during patients' surgical processes to minimize pain.
Germany contributes a significant share of 7.1% in the global market during the forecast period. The increasing number of cancer cases, rising disposable income, and diabetes patients are expanding Germany's patient-controlled analgesia pumps market.
Key companies are developing advanced technical healthcare devices to enhance patient outcomes. They are offering flexible, cost-effective, portable, and improved devices to satisfy end users' demand; according to a report by the WHO, around 628,519 new cases of cancer disease found in Germany in 2020. These incidences are uplifting the demand for patient-controlled analgesia pumps in the country.
China is one of the significant countries that secured a CAGR of 5.1% in the global market during the forecast period. The increasing old age population, advanced healthcare technologies, and essential key players are expanding the China patient-controlled Analgesia pumps market.
In 2019, according to the WHO report, 176 million people suffered from chronic diseases. The increasing generic population is raising the demand for patient-controlled analgesia pumps. The growing pharmaceuticals, healthcare services, and medical devices are contributing significant role in the country.
The integration of artificial intelligence and the Internet of Things in healthcare devices by essential key manufacturers is surging the China market. These manufacturers are regulating stringent regulations to offer high-quality products.
Japan is estimated to capture a share of 4.3% in the global market during the forecast period. Emerging economies, a high standard of living, and growing technologies are fueling the Japan market. On the other hand, the increasing population of the aging demographic is surging the demand for patient-controlled analgesia pumps.
Patients prefer high-quality, better service, and cost-effective solutions to improve their health conditions. Japan is a hub of innovation and technology. Healthcare providers adopting cutting-edge technologies such as robotics, automation, and electronics are driving the Japan market.
Japanese companies are adopting several strategies to build trustworthy relationships with their clients. The distribution channels play a crucial role in expanding global reach and finding relevant end users. They understand the needs of products and services across various end-use industries and are advancing Japan's market share.
India is estimated to secure a CAGR of 5.3% in the global market by 2033. The rising medical tourism enhanced medical treatment, and high-quality services are fueling India's patient-controlled analgesia pumps market. The government initiated several programs to offer healthcare services at lower costs. The highly skilled workforce is largely enhancing patients' healthcare with essential healthcare devices.
The rising pharmaceutical sector, innovations in drug therapies, and smart machine technologies are playing crucial roles in hospitals. Manufacturers are offering smart devices at affordable prices are fulfill end users' requirements. The rising urbanization, industrialization, and preferring patients' choice of treatment are advancing the Indian market.
Principal Consultant
| Category | PCA Pumps |
|---|---|
| Share | 75.5% |
Based on product type, PCA pumps are estimated to capture a share of 75.5% during the forecast period. The demand for PCA pumps is widely increasing among hospitals to manage patients' pain after medical conditions and surgeries. These patient-managed pain relief pumps offer effective and flexible methods to relieve pain.
PCA pumps reduce the workload of service staff by providing self-administered medication. These pain relief pumps play a crucial role in patient care. PCA pumps are managing cancer pain with feature-rich devices and advanced medical devices. These factors are estimated to dominate the PCA pumps in the global market by 2033. On the other hand, pump accessories are also significantly fueling the global market by registering a better share of the market.
| Category | Chemo therapy/ oncology |
|---|---|
| Share | 36.6% |
Based on application, the chemotherapy/oncology segment is likely to dominate the global market by capturing a share of 36.6% by 2033. The growing incidence of cancer is increasing the demand for chemotherapy/ oncology services to treat patients. The aging population suffers more prevalence of chronic disease, increasing the adoption of chemotherapy/ oncology services.
The growing technological advancements in diagnostic and cancer research institutions are improving chemotherapy to treat patients. The innovation of new drug therapies and other oncology therapies is advancing the global market revenue.
The growing awareness of early detection of cancer, awareness programs, and standardized treatment are increasing the demand for chemotherapy/ oncology. Pharmaceutical sectors are investing hugely in research and development activities.
| Category | Hospital |
|---|---|
| Share | 56.9% |
Based on end-users, the hospital segment is likely to dominate the global market by registering a share of 56.9% by 2033. Rising diverse patients are increasing the demand for better healthcare services and products. Hospitals provide various healthcare specialists to treat patients' diseases, from medicine to surgical procedures.
The broad variety of services, advanced medical equipment, and suppliers are surging the global market size. Hospitals offer outpatient and inpatient services with the adoption of medical devices.
Hospitals offer excellent teaching facilities to enhance patient outcomes with their expertise. The government initiative plans a broader hospital sector to manage emergency medical care. It provides rehabilitation services for its patients.
Key players are playing a crucial role in highlighting global market revenue upward. They analyze and research on market and come out with unique and advanced ideas to develop improved products. These key players are adopting various marketing methodologies such as mergers, collaborations, acquisitions, product launches, and partnerships.
Key market players are improving patients' health with their highly equipped healthcare devices. They are supporting their customers with their standardized products. These key players make their efforts to provide suitable devices and take feedback from their relevant consumers. They are changing their products according to end users' preferences with easy-to-use machines.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Recent Developments in the Patient-controlled Analgesia Pumps Market
The patient-controlled analgesia pumps market valuation is USD 729.1 million in 2023.
The United States is the biggest market for patient-controlled analgesia pumps.
The patient-controlled analgesia pumps market is likely to capture a CAGR of 5% in 2023.
The growing focus on portable patient-controlled analgesia devices.
ICU Medical, Ace Medical Co. Ltd., and Baxter International are the key players in the patient-controlled analgesia market.
1. Executive Summary 2. Market Overview 3. Market Background 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product 5.1. PCA Pumps 5.2. Pump Accessories 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application 6.1. Chemo Therapy/Oncology 6.2. Pediatrics/Neonatology 6.3. Gastroenterology 6.4. Hematology 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End-User 7.1. Hospitals 7.2. Ambulatory Surgical Centers 7.3. Home care settings 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 8.1. North America 8.2. Latin America 8.3. Western Europe 8.4. Eastern Europe 8.5. South Asia and Pacific 8.6. East Asia 8.7. Middle East and Africa 9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 16. Key Countries Market Analysis 17. Market Structure Analysis 18. Competition Analysis 18.1. Smiths Group plc. 18.2. Fresenius Kabi Group 18.3. Hospira (Pfizer Inc.) 18.4. Micrel Medical Devices 18.5. Ace Medical Co. Ltd. 18.6. Terumo Corporation 18.7. B.Braun Melsungen AG 18.8. Baxter International 18.9. Becton Dickinson and Company 18.10. BD 18.11. ICU Medical 19. Assumptions & Acronyms Used 20. Research Methodology
Explore Healthcare Insights
View Reports
Patient-Controlled Analgesia Pumps Market
